Medical Device Marketing Under Substantial Equivalence – FDA Clearance and USPTO Patent Consideration

Date: September 01, 2018

Publication: Regulatory Focus

Robert Guzman and Clifton McCann’s article “Medical Device Marketing Under Substantial Equivalence – FDA Clearance and USPTO Patent Consideration,” was featured in September 2018 issue of Regulatory Focus in September 2018.

Read more.